Navigation Links
California's Historic RN-to-Patient Hospital Staffing Ratios Upgraded Again With New Year
Date:1/3/2008

working with the Massachusetts Nurses Association on a proposed ratio law in their state. "RNs across the nation have seen the future, and the enormous benefits of this law. They know it works for patients, nurses, and communities," said Cortez.

AB 394, authored by current California State Sen. Sheila Kuehl and sponsored by CNA/NNOC, was signed in 1999 by then Gov. Gray Davis. It directed the state health department to determine the specific ratios, a process that took several years and involved multiple public hearings.

The hospitals, which lobbied extensively to block the law, filed a lawsuit in Dec. 2003 to repeal key portions of the law. The suit failed.

The hospitals then persuaded Gov. Arnold Schwarzenegger to issue an emergency regulation in Nov. 2004 to overturn emergency room ratios and improved medical/surgical ratios. In response, CNA/NNOC launched over 100 protests against Schwarzenegger in addition to a lawsuit. Subsequently a California court overturned Schwarzenegger's regulation as illegal, and a protest movement launched by CNA/NNOC defeated four Schwarzenegger-ballot initiatives in a 2005 special election.

Schwarzenegger has subsequently dropped the fight against the law, and the California Department of Public Health has sent letters to hospitals notifying them of their obligation to meet the standards and improve the ratios on Jan. 1.

The letters also reiterate that hospitals must increase staffing beyond the ratios if needed by patient acuity: "Hospitals must ensure that they are staffed to assure that the needs of the patients are met ... Hospitals are reminded that the regulations only reflect the minimum standards for staffing."

"Hospital industry efforts to overturn the law have failed due to their enormous popularity with patients and the public, support from legislators, validation from the courts, and their demonstrated success in improving patient care," Cortez said.

RNs who have experien
'/>"/>

SOURCE California Nurses Association
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Historic Abortion Case; Acuna V. Turkish
2. Live Webcast With President George H.W. Bush as Bono and DATA Are Honored With National Constitution Centers 2007 Liberty Medal in Historic Philadelphia
3. Filing for Reconsideration/Press Conference ACUNA v. TURKISH, Historic Informed Consent Abortion Case to the New Jersey Supreme Court
4. Grand Opening of Regence Boys & Girls Club Marks a Milestone in Historic New Columbia Community Revitalization
5. Historic Breast Cancer Global Advocate Summit Convenes in Budapest, Hungary on September 29-30
6. Asbestos No More: Historic Asbestos Ban Passage Imminent
7. A Breath of Fresh Air From Washington: Senate Passes Historic Asbestos Ban
8. NDPA Urges Passage of Historic Pool Bill
9. Historic Agreement Reached to More Expertly and Efficiently Expand Proton Therapy Worldwide
10. Historic Global Vigil for AIDS Orphans Ends in New York City
11. New research explores newborn in-hospital weight loss
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/5/2008)...G, Pa., Sept. 5 /PRNewswire-USNewswire/ -- Childre...r access to comprehensive,services to protect thei...n,in grants that were announced today by the Depar...vices for children and families, the department,be...ren,s Services Planning,initiative, ICSP, in 2004....
(Date:9/5/2008)..., Md., Sept. 5 /PRNewswire-USNewswire/ -- The Heal...day announced $39 million in grants to,increase an...centers., "These grants continue President Bush,s...whose services now reach more economically,vulnera...r before," HRSA,Administrator Elizabeth M. Duke sa...
(Date:9/5/2008)...ontrolled, but you need to know what triggers them...thDay News) -- If you are one of the 36 million Am...is nowhere in the United States that is free from ... shows. , Allergies don,t only happen in the sp...ell. In the fall, the most challenging cities to l...
(Date:9/5/2008)...N, Sept. 5 /PRNewswire-USNewswire/ -- Speaker Nanc...upport of the aims of the "Stand,Up to Cancer" tel...re is not a person in our country who has not seen...s 565,000 Americans annually, and each,year there ... must work,together to make eradicating the scourg...
Breaking Medicine News(10 mins):Health News:Pennsylvania Counties Receive Grants to Improve Services for Children 2Health News:HRSA Announces $39 Million in Grants to Expand, Improve Health Center Services 2Health News:No Place Safe From Allergies 2
...ectually disabled Australians will soon enjoy bett...new Medicare rebate created// at the AMA’s urging,...group, people with an intellectual disability have...any Australians, mostly because they can find it d...
... with mesothelioma — a form of cancer associated w...e when treated with a combination// of two cancer ...ma, a rare but aggressive form of cancer that occu...gs, heart and abdomen, is associated with exposure...
... A botched up family planning operation would have...ing British doctor of Indian origin// wasn't there...ctor Ashok Vardhan's visit to Purnea district, 300...ti Devi, who was comatose after a portion of her l...
...ientists have come out strongly against the NHS's ...r to those in the age group 25 to 29, leaving// o...e doctors, Consultant cytopathologists Amanda Herb...dation Trust in London, and John Smith, from the R...
Other Medicine News:Health News:Chemo Combination Improves Survival in Asbestos-Related Cancer 2Health News:Chemo Combination Improves Survival in Asbestos-Related Cancer 3Health News:Extend Cervical Smears to Younger Women, Insist Specialists 2
(Date:9/4/2008)...Patient Identification for Targeted Therapies ...tment HUNTINGTON BEACH, Calif., and AMSTERDAM, ...rld leader in molecular cancer diagnostics,today ...nostic test that,allows physicians to quantitative...rogen receptor (ER), progesterone receptor (PR) an...
(Date:9/3/2008)...t. 3 /- Simcere,Pharmaceuti...d supplier of,branded generic pharmaceuticals and ...roduct Endu (also known as Endostar) in China,ann...al study., At the request of the SFDA, Simcere in...ate the safety and therapeutic efficacy of Endu, a...
(Date:9/3/2008)...nd GENEVA, Sept. 3 /- Artelis SA and,...based monoclonal antibody,production with the achi...er liter. This record level was accomplished by ap...igh-performance stable Selexis CHO,production cell...ists at,Selexis SA using their proprietary Selexis...
(Date:9/3/2008)...rations, Updates Zingo Launch Progress and Adlea ... Conference Call Today at 11:30 am ET, ...FirstCall/ -- Anesiva,Inc. (Nasdaq: ANSV ) annou...tions to focus on commercial and late-stage produc...ecialty pharmaceutical pain management,company. Th...
Breaking Medicine Technology:Agendia Launches TargetPrint(R) for Breast Cancer Patients 2Simcere Pharmaceutical Group Announces Interim Results of Endu Phase IV Clinical Study 2Simcere Pharmaceutical Group Announces Interim Results of Endu Phase IV Clinical Study 3Artelis and Selexis Report Record Antibody Production Levels in CHO Cells of Over 31 Grams Per Liter 2Artelis and Selexis Report Record Antibody Production Levels in CHO Cells of Over 31 Grams Per Liter 3Anesiva Accelerates Its Transition to Specialty Pharma Pain Management Company 2Anesiva Accelerates Its Transition to Specialty Pharma Pain Management Company 3Anesiva Accelerates Its Transition to Specialty Pharma Pain Management Company 4Anesiva Accelerates Its Transition to Specialty Pharma Pain Management Company 5Singapore Is One of the Fastest Growing Bioclusters in Asia 3B Wave of Investments in Drug Discovery and Translational Research 22083 1Singapore Is One of the Fastest Growing Bioclusters in Asia 3B Wave of Investments in Drug Discovery and Translational Research 22083 2Singapore Is One of the Fastest Growing Bioclusters in Asia 3B Wave of Investments in Drug Discovery and Translational Research 22083 3Singapore Is One of the Fastest Growing Bioclusters in Asia 3B Wave of Investments in Drug Discovery and Translational Research 22083 4Singapore Is One of the Fastest Growing Bioclusters in Asia 3B Wave of Investments in Drug Discovery and Translational Research 22083 5Singapore Is One of the Fastest Growing Bioclusters in Asia 3B Wave of Investments in Drug Discovery and Translational Research 22083 6150 Years Later House Divided Speech Still Holds Strong Message 22081 1150 Years Later House Divided Speech Still Holds Strong Message 22081 2AHIP Selects HealthTrio to Join AHIP Solutions Program 22079 1AHIP Selects HealthTrio to Join AHIP Solutions Program 22079 2Gentiva 28R 29 Health Services to Present June 24 at Jefferies 2nd Annual Healthcare Conference in New York 22077 1Gentiva 28R 29 Health Services to Present June 24 at Jefferies 2nd Annual Healthcare Conference in New York 22077 2Gentiva 28R 29 Health Services to Present June 24 at Jefferies 2nd Annual Healthcare Conference in New York 22077 3
...- Cytogen,Corporation (NASDAQ: CYTO) reported upda...uating QUADRAMET(R) (samarium Sm-153,lexidronam in...),Millennium Pharmaceuticals, Inc.) in patients w...ts were presented today in a,poster titled, "Phase... Multiple Myeloma," by James Berenson, M.D., Medic...
...tion against,infection with virus types beyond 16 ...ine, PHILADELPHIA, June 27, 2007 /PRNewswire-First...se III study show that,CERVARIX(R), the GlaxoSmith...up to 100 percent protection against advanced prec...f human papillomavirus,types 16 and 18. The study...
Other Medicine Technology:Cytogen Presents Phase 1 Data Showing Promising Antitumor Activity,and Safety Profile of Quadramet at International Myeloma Workshop 2Cytogen Presents Phase 1 Data Showing Promising Antitumor Activity,and Safety Profile of Quadramet at International Myeloma Workshop 3Cytogen Presents Phase 1 Data Showing Promising Antitumor Activity,and Safety Profile of Quadramet at International Myeloma Workshop 4Cytogen Presents Phase 1 Data Showing Promising Antitumor Activity,and Safety Profile of Quadramet at International Myeloma Workshop 5Cytogen Presents Phase 1 Data Showing Promising Antitumor Activity,and Safety Profile of Quadramet at International Myeloma Workshop 6Cytogen Presents Phase 1 Data Showing Promising Antitumor Activity,and Safety Profile of Quadramet at International Myeloma Workshop 7Cytogen Presents Phase 1 Data Showing Promising Antitumor Activity,and Safety Profile of Quadramet at International Myeloma Workshop 8Largest Cervical Cancer Vaccine Efficacy Trial Shows Cervarix,Provides Excellent Protection Against Lesions Caused by Most Common,Cancer-Causing Virus Types 2Largest Cervical Cancer Vaccine Efficacy Trial Shows Cervarix,Provides Excellent Protection Against Lesions Caused by Most Common,Cancer-Causing Virus Types 3Largest Cervical Cancer Vaccine Efficacy Trial Shows Cervarix,Provides Excellent Protection Against Lesions Caused by Most Common,Cancer-Causing Virus Types 4Largest Cervical Cancer Vaccine Efficacy Trial Shows Cervarix,Provides Excellent Protection Against Lesions Caused by Most Common,Cancer-Causing Virus Types 5Largest Cervical Cancer Vaccine Efficacy Trial Shows Cervarix,Provides Excellent Protection Against Lesions Caused by Most Common,Cancer-Causing Virus Types 6Largest Cervical Cancer Vaccine Efficacy Trial Shows Cervarix,Provides Excellent Protection Against Lesions Caused by Most Common,Cancer-Causing Virus Types 7
...ment introduction. The design of the introducer fe...ition profile between the introducer sheath and in...h fascial tissue and strictured areas. Proximal re...ducer sheath and introducer dilator during sheath ...
Used for catheter or instrument introduction. The dual knobs allow the sheath to be peeled away and removed. The maximum diameter of the catheter or instrument to be introduced should be measured to
Used to establish a percutaneous tract into the renal pelvis for catheter placement or stone manipulation. Supplied sterile in peel-open packages. Intended for one-time use.
Used for antegrade placement of a safety wire guide prior to endourological procedures. Supplied sterile in peel-open packages. Intended for one-time use.
Medicine Products: